Russell Investments Group, Ltd. F Star Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$4.09 - $6.86 $239,620 - $401,906	-58,587 Reduced 11.94%	432,125 $2.73 Million
Q3 2022 Nov 04, 2022	BUY	$5.41 - $6.74 $628,436 - $782,931	116,162 Added 31.01%	490,712 $2.51 Million
Q2 2022 Jul 29, 2022	SELL	$2.18 - $6.39 $494,519 - $1.45 Million	-226,844 Reduced 37.72%	374,550 $2.34 Million
Q1 2022 May 05, 2022	BUY	$2.77 - $5.36 $986,998 - $1.91 Million	356,317 Added 145.39%	601,394 $2.13 Million
Q4 2021 Jan 21, 2022	BUY	$4.71 - $7.38 $319,295 - $500,297	67,791 Added 38.24%	245,077 $1.23 Million
Q3 2021 Nov 08, 2021	BUY	$5.2 - $8.42 $13,067 - $21,159	2,513 Added 1.44%	177,286 $1.3 Million
Q2 2021 Aug 04, 2021	BUY	$6.57 - $10.71 $1.15 Million - $1.87 Million	174,773 New	174,773 $1.5 Million

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.